Medication

This photo provided by Novartis shows Zolgensma. The one-time gene therapy developed by Novartis, Zolgensma, will cost $2.125 million. It treats a rare condition called spinal muscular atrophy, or SMA, which strikes about 400 babies born in the U.S. each year. The therapy, given in a one-hour infusion, was approved for children under age 2 and will be available within two weeks. (Novartis via AP)
May 24, 2019 - 5:15 pm
U.S. regulators have approved the most expensive medicine ever, for a rare disorder that destroys a baby's muscle control and kills nearly all of those with the most common type of the disease within a couple of years. The treatment is priced at $2.125 million. Out-of-pocket costs for patients will...
Read More
Two people ask to take a photo with House Judiciary Committee Chairman Jerrold Nadler, D-N.Y., center, as the Senate and the House of Representatives shut down for the week-long Memorial Day recess, at the Capitol in Washington, Thursday, May 23, 2019. Rep. Nadler, whose district covers parts of Manhattan and Brooklyn in New York, has gained notoriety by leading one of the House committees investigating President Donald Trump. (AP Photo/J. Scott Applewhite)
May 23, 2019 - 2:49 pm
WASHINGTON (AP) — Plunging ahead despite paralyzing partisanship in the nation's capital, senior lawmakers of both parties Thursday proposed legislation to tackle "surprise medical bills" and other concerns, from prescription drug costs to uneven vaccination rates. The draft bill from Sens. Lamar...
Read More
Rep. Anna Eshoo, D-Calif., right, chair of the House Health Subcommittee, says President Donald Trump and Attorney General William Barr want to take a sledgehammer to health care, as she joins, from left, Rep. Lisa Blunt Rochester, D-Del., House Speaker Nancy Pelosi, D-Calif., and Senate Minority Leader Chuck Schumer, D-N.Y., at a Democratic event ahead of a House floor vote on the Health Care and Prescription Drug Package, at the Capitol in Washington, Wednesday, May 15, 2019. (AP Photo/J. Scott Applewhite)
May 16, 2019 - 8:07 pm
WASHINGTON (AP) — Democrats pushed legislation buttressing the 2010 health care law and curbing prescription drug prices through the House Thursday, advancing a bill that has no chance of surviving in the Senate or getting President Donald Trump's signature and seemed engineered with next year's...
Read More
May 09, 2019 - 7:11 pm
WASHINGTON (AP) — The Health and Human Services Department announced Thursday that California-Based Gilead Sciences Inc. has agreed to donate medications that reduce the risk of HIV transmission for up to 200,000 people a year. "Will help us achieve our goal of ending the HIV epidemic in America!"...
Read More
FILE - In this March 13, 2019, file phtooHealth and Human Services Secretary Alex Azar testifies before a House Appropriations subcommittee on Capitol Hill in Washington. Azar says drugmakers will soon have to reveal prices of their prescription medicines in those ever-present TV ads. The Trump administration will issue final regulations on May 8 requiring drug companies to disclose list prices of medications costing more than $35 for a month’s supply. Azar tells The Associated Press if drugmakers are scared to put prices in ads that means they should lower those prices. (AP Photo/Susan Walsh, File)
May 08, 2019 - 3:28 pm
WASHINGTON (AP) — TV pitches for prescription drugs will soon include the price, giving consumers more information upfront as they make medication choices at a time when new drugs can carry anxiety-inducing prices. Health and Human Services Secretary Alex Azar said Wednesday the Trump...
Read More
South Africa's Caster Semenya crosses the line to win the gold in the women's 800-meter final during the Diamond League in Doha, Qatar, Friday, May 3, 2019. (AP Photo/Kamran Jebreili)
May 03, 2019 - 4:25 pm
Caster Semenya was defiant in every way at what very well could be her last 800 meter race. Her raised fist at the start. Her unstoppable victory. And with her reply Friday to the big question of whether she will now submit to new testosterone regulations in track and field and take hormone-...
Read More
In this Friday, April 26, 2019 photo, a box of RELPAX migraine pills manufactured by Pfizer are arranged for a photo in Doral, Fla. Pfizer Inc. reports financial results Tuesday, April 30. (AP Photo/Wilfredo Lee)
April 30, 2019 - 1:33 pm
Higher prescription drugs sales and restrained spending together gave drugmaker Pfizer a 9% jump in first quarter profit as it easily topped analysts' profit expectations. Investors drove up Pfizer shares $1.28, or 3.2%, to $40.87 in early afternoon trading. Sales of breast cancer drug Ibrance and...
Read More
FILE - In this Jan. 30, 2019 file photo, employees prune marijuana plants at a Fotmer SA, greenhouse in Nueva Helvecia, Uruguay. On April 24, 2019, Fotmer in Uruguay and another company in Colombia announced they will become the first to export legal medical marijuana products from Latin America to Europe, part of what the firms hope will become a growing trade. (AP Photo/Matilde Campodonico, File)
April 24, 2019 - 9:41 pm
MONTEVIDEO, Uruguay (AP) — Two companies from Uruguay and Colombia will become the first in Latin America to export medical marijuana products to Europe under deals announced Wednesday. Fotmer Life Sciences of Uruguay and Clever Leaves of Colombia will export cannabis extract and dried marijuana...
Read More
FILE - In this Monday, Sept. 24, 2018 file photo, a patient undergoes dialysis at a clinic in Sacramento, Calif. Results of a study released on Sunday, April 14, 2019 show that the diabetes drug Invokana has been shown to help prevent or delay worsening of kidney disease, which causes millions of deaths each year and requires hundreds of thousands of people to use dialysis to stay alive. (AP Photo/Rich Pedroncelli)
April 14, 2019 - 8:08 pm
A new study shows that a drug used to help control blood sugar in people with diabetes also can prevent or slow kidney disease, which causes millions of deaths each year and requires hundreds of thousands of people to use dialysis to stay alive. Doctors say it's hard to overstate the importance of...
Read More
April 12, 2019 - 3:15 pm
TRENTON, N.J. (AP) — Gov. Phil Murphy on Friday signed legislation making New Jersey the seventh state to enact a law permitting terminally ill patients to seek life-ending medication. New Jersey will join six other states and the District of Columbia that have similar laws once it goes into effect...
Read More

Pages